human peptide derivatives

Human peptide derivatives (HPD) refer to a therapeutic intervention consisting of specific peptide sequences, potentially derived from human biological tissues or synthetically produced to mimic human signaling molecules, utilized for regenerative medicine. In clinical trials conducted by the Mastercell Stem Cell Centre in Australia, these derivatives are administered via intra-articular injection to patients with moderate to severe knee osteoarthritis. The treatment aims to leverage the bioactivity of peptides to reduce joint inflammation, promote cartilage repair, and alleviate pain, serving as a biological alternative or adjunct to treatments like platelet-rich plasma (PRP) or adipose-derived stem cell therapies. The specific composition of the HPD used in these trials is often proprietary, focusing on modulating the intra-articular environment to improve joint function.

Other names

human peptide derivativeshuman peptide derivative injectionsHPD